Brucine-loaded liposomes composed of HSPC and DPPC at different ratios: in vitro and in vivo evaluation

References

• Lindner LH, Hossann M. Factors affecting drug release from liposomes. Curr Opin Drug Disc 2011;13:111–23
   Web of Science ®Google Scholar
• Koning GA, Eggermont A, Lindner LH, tenHagen TLM. Hyperthermia and thermosensitive liposomes for improved delivery of chemotherapeutic drugs to solid tumors. Pharm Res 2010;27:1750–4
   PubMed Web of Science ®Google Scholar
• Tagami T, Ernsting MJ, Li SD. Efficient tumor regression by a single and low dose treatment with a novel and enhanced formulation of thermosensitive liposomal doxorubicin. J Control Release 2011;152:303–9
   PubMed Web of Science ®Google Scholar
• Gaber MH, Wu NZ, Hong K, et al. Thermosensitive liposomes: extravasation and release of contents in tumor microvascular networks. Int J Radiat Oncol Bio Phys 1996;36:1177–87
   PubMed Web of Science ®Google Scholar
• Chen J, Cheng D, Li J, et al. Influence of lipid composition on the phase transition temperature of liposomes composed of both DPPC and HSPC. Drug Dev Ind Pharm 2012; [Epub ahead of print]. DOI: 10.3109/03639045.2012.668912
   Web of Science ®Google Scholar
• Deng XK, Yin W, Li WD, et al. The anti-tumor effects of alkaloids from the seeds of strychnos nux-vomica on HepG2 cells and its possible mechanism. J Ethnopharmacol 2006;106:179–86
   PubMed Web of Science ®Google Scholar
• Yin W, Deng XK, Yin FZ, et al. The cytotoxicity induced by brucine from the seed of Strychnos nux-vomica proceeds via apoptosis and is mediated by cyclooxygenase 2 and caspase 3 in SMMC 7721 cells. Food Chem Toxicol 2007;45:1700–8
   PubMed Web of Science ®Google Scholar
• Rao PS, Ramanadham M, Prasad MNV. Anti-proliferative and cytotoxic effects of Strychnos nux-vomica root extract on human multiple myeloma cell line-RPMI 8226. Food Chem Toxicol 2009;47:283–8
   PubMed Web of Science ®Google Scholar
• Chen J, Lin AH, Chen ZP, et al. Ammonium sulfate gradient loading of brucine into liposomes: effect of phospholipid composition on entrapment efficiency and physicochemical properties in vitro. Drug Dev Ind Pharm 2010;36:245–53
   PubMed Web of Science ®Google Scholar
• Li J, Chen J, Cai BC, Yang T. Preparation, characterization and tissue distribution of brucine stealth liposomes with different lipid composition. Pharm Dev Technol 2011; [Epub ahead of print]. DOI: 10.3109/10837450.2011.598165
   Web of Science ®Google Scholar
• Chen J, Hou T, Fang Y, et al. HPLC determination of strychnine and brucine in rat tissues and the distribution study of processed semen strychni. Yakugaku Zasshi 2011;131:721–9
   PubMed Web of Science ®Google Scholar
• Anderson M and Omri A. The effect of different lipid components on the in vitro stability and release kinetics of liposome formulations. Drug Deliv 2004;11:33–9
   PubMed Web of Science ®Google Scholar
• Hossann M, Wang T, Wiggenhorn M, et al. Size of thermosensitive liposomes influences content release. J Control Release 2010;147:436–43
   PubMed Web of Science ®Google Scholar
• Qin JM, Yin PH, Li Q, et al. Anti-tumor effects of brucine immuno-nanoparticles on hepatocellular carcinoma. Int J Nanomed 2012;7:369–79
   PubMed Web of Science ®Google Scholar
• Knudsen NØ, Jorgensen L, Hansen J, et al. Targeting of liposome-associated calcipotriol to the skin: effect of liposomal membrane fluidity and skin barrier integrity. Int J Pharm 2011;416:478–85
   PubMed Web of Science ®Google Scholar
• Gaber MH. Effect of bovine serum on the phase transition temperature of cholesterol-containing liposomes. J Microencapsul 1998;15:207–14
   PubMed Web of Science ®Google Scholar
• El Maghraby GMM, Williams AC, Baryy BW. Interactions of surfactants (edge activators) and skin penetration enhancers with liposomes. Int J Pharm 2004;276:143–61
   PubMed Web of Science ®Google Scholar
• Djanashvili K, tenHagen TLM, Blangé R, et al. Development of a liposomal delivery system for temperature-triggered release of a tumor targeting agent, Ln(III)-DOTA-phenylboronate. Bioorgan Med Chem 2011;19:1123–30
   PubMed Web of Science ®Google Scholar
• Hossann M, Wiggenhorn M, Schwerdt A, et al. In vitro stability and content release properties of phosphatidylglyceroglycerol containing thermosensitive liposomes. Biochim Biophys Acta 2007;1768:2491–9
   PubMed Web of Science ®Google Scholar
• Smet M, Langereis S, Bosch S, Grüll H. Temperature-sensitive liposomes for doxorubicin delivery under MRI guidance. J Control Release 2010;143:120–7
   PubMed Web of Science ®Google Scholar
• Gaber MH. Modulation of doxorubicin resistance in multidrug-resistance cells by targeted liposomes combined with hyperthermia. J Biochem Mol Biol Biophys 2002;6:309–14
   PubMedGoogle Scholar
• Kuntsche J, Freisleben I, Steiniger F, Fahr A. Temoporfin-loaded liposomes: physicochemical characterization. Eur J Pharm Sci 2010;40:305–15
   PubMed Web of Science ®Google Scholar
• Kan P, Tsao CW, Wang AJ, et al. A liposomal formulation able to incorporate a high content of paclitaxel and exert promising anticancer effect. J Drug Deliv 2011; [Epub ahead of print]. doi:10.1155/2011/629234
   Google Scholar
• Chapman D, Urbina J. Biomembrane phase transitions: studies of lipid-water systems using differential scanning calorimeter. J Biol Chem 1974;249:2512–21
   PubMed Web of Science ®Google Scholar
• Zhang L, Lu CT, Li WF, et al. Physical characterization and cellular uptake of propylene glycol liposomes in vitro. Drug Dev Ind Pharm 2012;38:365–71
   PubMed Web of Science ®Google Scholar